Resthetics recycles waste anesthetic gas into a renewable resource, reducing HFC release and creating a cost-effective market.
1
Operating
2015
Houston, TX, US🇺🇸United States
Resthetics, founded in 2015, aims to convert waste anesthetic gas into a renewable resource. Originating from interdisciplinary research at the University of Houston, the company developed a porous crystalline organic framework with a high affinity for fluorinated anesthetics. This technology allows for the efficient capture and desorption of anesthetic molecules, significantly reducing harmful HFC emissions. Resthetics focuses on selling recaptured fluorinated anesthetics, targeting the healthcare and environmental sustainability markets.
Notable affiliated individuals include researchers from the University of Houston who contributed to the core technology. The company has attracted attention from investors interested in green technologies and sustainable healthcare solutions. Key achievements include the development of a patented process capable of capturing 99.5% of exhausted anesthetic gases, which has been recognized in various scientific publications. Resthetics has made a significant impact by promoting environmental sustainability and offering cost-effective solutions for healthcare facilities.
Quick Facts
How much disclosed funding has Resthetics raised?
As of Feb 21, 2018, Resthetics has disclosed funding of $2k (USD).
